TEMPLATE: CLINICAL STUDY PROTOCOL

Reporting of adverse reactions to the FDA. Written IND Safety Reports. The Sponsor-Investigator will submit a written IND Safety Report (i.e., completed FDA Form 3500 A) to the responsible new drug review division of the FDA for any observed or volunteered adverse event that is determined to be a serious and unexpected, suspected adverse reaction. ................
................